saNOtize Research and Development Corp. products

VirX and enovid are identical formulations based on our NORS (Nitric Oxide Releasing Solution) platform technology. They have the same active ingredients and mechanisms of action as those nasal therapeutics used in our clinical trials.

VirX and enovid are identical formulations based on our NORS (Nitric Oxide Releasing Solution) platform technology. They have the same active ingredients and mechanisms of action as those nasal therapeutics used in our clinical trials.

NORS2791 product candidate is a topical formulation of NORSTM developed for the treatment of onychomycosis, a fungal infection of the nail. In patients diagnosed with this infection, NORSTM will be delivered via a specially-designed bandage containing a NO releasing gel.